Circulating levels of SPARC are increased in obesity and diabetes in both mice and humans, and mice with SPARC deficiency exhibit impaired glucose homeostasis and insulin secretion [222, 223]. Here, SPARC is linked to obesity due to melanocortin 4 receptor deficiency.